Show simple item record

dc.contributor.authorSeebacher, Nicole
dc.contributor.authorLane, Darius JR
dc.contributor.authorRichardson, Des R
dc.contributor.authorJansson, Patric J
dc.date.accessioned2021-10-18T01:24:48Z
dc.date.available2021-10-18T01:24:48Z
dc.date.issued2016
dc.identifier.issn0891-5849
dc.identifier.doi10.1016/j.freeradbiomed.2016.04.201
dc.identifier.urihttp://hdl.handle.net/10072/409159
dc.description.abstractOxidative stress plays a role in the development of drug resistance in cancer cells. Cancer cells must constantly and rapidly adapt to changes in the tumor microenvironment, due to alterations in the availability of nutrients, such as glucose, oxygen and key transition metals (e.g., iron and copper). This nutrient flux is typically a consequence of rapid growth, poor vascularization and necrosis. It has been demonstrated that stress factors, such as hypoxia and glucose deprivation up-regulate master transcription factors, namely hypoxia inducible factor-1α (HIF-1α), which transcriptionally regulate the multi-drug resistance (MDR), transmembrane drug efflux transporter, P-glycoprotein (Pgp). Interestingly, in addition to the established role of plasma membrane Pgp in MDR, a new paradigm of intracellular resistance has emerged that is premised on the ability of lysosomal Pgp to transport cytotoxic agents into this organelle. This mechanism is enabled by the topological inversion of Pgp via endocytosis resulting in the transporter actively pumping agents into the lysosome. In this way, classical Pgp substrates, such as doxorubicin (DOX), can be actively transported into this organelle. Within the lysosome, DOX becomes protonated upon acidification of the lysosomal lumen, causing its accumulation. This mechanism efficiently traps DOX, preventing its cytotoxic interaction with nuclear DNA. This review discusses these effects and highlights a novel mechanism by which redox-active and protonatable Pgp substrates can utilize lysosomal Pgp to gain access to this compartment, resulting in catastrophic lysosomal membrane permeabilization and cell death. Hence, a key MDR mechanism that utilizes Pgp (the "gun") to sequester protonatable drug substrates safely within lysosomes can be "turned on" MDR cancer cells to destroy them from within.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherElsevier
dc.relation.ispartofpagefrom432
dc.relation.ispartofpageto445
dc.relation.ispartofjournalFree Radical Biology and Medicine
dc.relation.ispartofvolume96
dc.subject.fieldofresearchMedicinal and biomolecular chemistry
dc.subject.fieldofresearchBiochemistry and cell biology
dc.subject.fieldofresearchMedical biochemistry and metabolomics
dc.subject.fieldofresearchcode3404
dc.subject.fieldofresearchcode3101
dc.subject.fieldofresearchcode3205
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsBiochemistry & Molecular Biology
dc.subject.keywordsEndocrinology & Metabolism
dc.subject.keywordsROS
dc.titleTurning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationSeebacher, N; Lane, DJR; Richardson, DR; Jansson, PJ, Turning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance, Free Radical Biology and Medicine, 2016, 96, pp. 432-445
dcterms.dateAccepted2016-04-29
dc.date.updated2021-10-18T01:23:17Z
gro.hasfulltextNo Full Text
gro.griffith.authorRichardson, Des R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record